CYP19A1 and Obesity: The clinical trial “Impact of Obesity on the Efficacy of Endocrine Therapy with Aromatase Inhibitors” (NCT01758146) is currently evaluating the efficacy of adjuvant tamoxifen compared with letrozole and should provide more information on endocrine therapy selection in this important population.